Peer-influenced content. Sources you trust. No registration required. This is HCN.
Psychiatry Advisor
Recent studies indicate that while ketamine and ECT are equally effective for treating MDD, ketamine did not prove non-inferior to ECT for MDEs. Both treatments have distinct side effect profiles that are critical for clinical decision-making.
Psychiatry May 21st 2024
MDLinx
Physicians must be vigilant of the impact that various medications can have on sexual function, including those less commonly associated with sexual side effects, to ensure holistic patient care and adherence to treatment.
All Specialties March 12th 2024
Consultant360
In this video, Dr. Charles Raison reveals how hyperthermia may harness the body’s immune response to combat major depressive disorder, suggesting a potential shift in non-pharmacological treatment strategies.
Psychiatry February 13th 2024
Medical Professionals Reference (MPR)
This case highlights the essential need for early follow-up and comprehensive patient education on medication effects, especially when managing patients with mental health disorders. It serves as a reminder of the delicate balance required in prescribing practices and patient care.
Internal Medicine February 13th 2024
Psych Congress Network
Rapid-acting antidepressants represent a pivotal development in depression treatment, targeting the glutamatergic system for quicker and more comprehensive symptom relief.
Psychiatry January 23rd 2024
Escitalopram shows promising results in the acute phase treatment of major depressive disorder, offering a potentially more effective and tolerable option for patients compared to other SSRIs and newer antidepressants.
Psychiatry January 17th 2024